Featured Products

My Quote Request

No products added yet

6505-01-230-9948

20 Products

POLYSPORIN OINTMENT

BACITRACIN ZINC AND POLYMYXIN B SULFATE OINTMENT,USP

NSN, MFG P/N

6505012309948

NSN

6505-01-230-9948

View More Info

POLYSPORIN OINTMENT

BACITRACIN ZINC AND POLYMYXIN B SULFATE OINTMENT,USP

NSN, MFG P/N

6505012309948

NSN

6505-01-230-9948

MFG

BURROUGHS WELLCOME CO

Description

ACTIVE INGREDIENT AND STRENGTH: 500.000 BACITRACIN ZINC UNITS PER GRAM AND 10000.000 POLYMYXIN B SULFATE UNITS PER GRAM
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BACITRACIN ZINC AND POLYMYXIN B SULFATE OINTMENT USP 0.5OZ TUBE
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,BURROUGHS WELLCOME
PRIMARY CONTAINER CONTENT QUANTITY: 0.500 OUNCES
PRIMARY CONTAINER TYPE: TUBE

NDC00168-0021-35

BACITRACIN ZINC AND POLYMYXIN B SULFATE OINTMENT,USP

NSN, MFG P/N

6505012309948

NSN

6505-01-230-9948

View More Info

NDC00168-0021-35

BACITRACIN ZINC AND POLYMYXIN B SULFATE OINTMENT,USP

NSN, MFG P/N

6505012309948

NSN

6505-01-230-9948

MFG

FOUGERA E AND CO

Description

ACTIVE INGREDIENT AND STRENGTH: 500.000 BACITRACIN ZINC UNITS PER GRAM AND 10000.000 POLYMYXIN B SULFATE UNITS PER GRAM
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BACITRACIN ZINC AND POLYMYXIN B SULFATE OINTMENT USP 0.5OZ TUBE
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,BURROUGHS WELLCOME
PRIMARY CONTAINER CONTENT QUANTITY: 0.500 OUNCES
PRIMARY CONTAINER TYPE: TUBE

POLYSPORIN

BACITRACIN ZINC AND POLYMYXIN B SULFATE OINTMENT,USP

NSN, MFG P/N

6505012309948

NSN

6505-01-230-9948

View More Info

POLYSPORIN

BACITRACIN ZINC AND POLYMYXIN B SULFATE OINTMENT,USP

NSN, MFG P/N

6505012309948

NSN

6505-01-230-9948

MFG

BURROUGHS WELLCOME CO

Description

ACTIVE INGREDIENT AND STRENGTH: 500.000 BACITRACIN ZINC UNITS PER GRAM AND 10000.000 POLYMYXIN B SULFATE UNITS PER GRAM
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BACITRACIN ZINC AND POLYMYXIN B SULFATE OINTMENT USP 0.5OZ TUBE
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,BURROUGHS WELLCOME
PRIMARY CONTAINER CONTENT QUANTITY: 0.500 OUNCES
PRIMARY CONTAINER TYPE: TUBE

NDC00536-3465-01

CHLORPROPAMIDE TABLETS,USP

NSN, MFG P/N

6505012310857

NSN

6505-01-231-0857

View More Info

NDC00536-3465-01

CHLORPROPAMIDE TABLETS,USP

NSN, MFG P/N

6505012310857

NSN

6505-01-231-0857

MFG

RUGBY GROUP INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS CHLORPROPAMIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: MEDSEP FOR DOD,RUGBY LABORATORIES INC.

135710

BENZTROPINE MESYLATE TABLETS,USP

NSN, MFG P/N

6505012310858

NSN

6505-01-231-0858

View More Info

135710

BENZTROPINE MESYLATE TABLETS,USP

NSN, MFG P/N

6505012310858

NSN

6505-01-231-0858

MFG

GENEVA PHARMACEUTICALS INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS BENZTROPINE MESYLATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: RATED BP

NDC00781-1357-10

BENZTROPINE MESYLATE TABLETS,USP

NSN, MFG P/N

6505012310858

NSN

6505-01-231-0858

View More Info

NDC00781-1357-10

BENZTROPINE MESYLATE TABLETS,USP

NSN, MFG P/N

6505012310858

NSN

6505-01-231-0858

MFG

GENEVA PHARMACEUTICALS INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS BENZTROPINE MESYLATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: RATED BP

DIMETAPP ELIXIR

BROMPHENIRAMINE MALEATE AND PHENYLPROPANOLAMINE HYDROCHLORIDE ELIXIR

NSN, MFG P/N

6505012311516

NSN

6505-01-231-1516

View More Info

DIMETAPP ELIXIR

BROMPHENIRAMINE MALEATE AND PHENYLPROPANOLAMINE HYDROCHLORIDE ELIXIR

NSN, MFG P/N

6505012311516

NSN

6505-01-231-1516

MFG

PHARMACEUTICAL BASICS INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS BROMPHENIRAMINE MALEATE ACTIVE INGREDIENT AND 12.500 MILLIGRAMS PHENYLPROPYLMETHYLAMINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FLAVOR: GRAPE
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE

NDC12280-0628-02

BROMPHENIRAMINE MALEATE AND PHENYLPROPANOLAMINE HYDROCHLORIDE ELIXIR

NSN, MFG P/N

6505012311516

NSN

6505-01-231-1516

View More Info

NDC12280-0628-02

BROMPHENIRAMINE MALEATE AND PHENYLPROPANOLAMINE HYDROCHLORIDE ELIXIR

NSN, MFG P/N

6505012311516

NSN

6505-01-231-1516

MFG

PHARMACEUTICAL BASICS INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS BROMPHENIRAMINE MALEATE ACTIVE INGREDIENT AND 12.500 MILLIGRAMS PHENYLPROPYLMETHYLAMINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FLAVOR: GRAPE
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE

NDC00054-4392-25

HYDROMORPHONE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505012313416

NSN

6505-01-231-3416

View More Info

NDC00054-4392-25

HYDROMORPHONE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505012313416

NSN

6505-01-231-3416

MFG

BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS HYDROMORPHONE HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

NDC00173-0380-32

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505012314806

NSN

6505-01-231-4806

View More Info

NDC00173-0380-32

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505012314806

NSN

6505-01-231-4806

MFG

GLAXO WELLCOME INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME FOR INJECTION USP 1GM BOTTLE 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE
SPECIAL FEATURES: BOTTLE WITH A RATED CAPACITY OF NOT LESS THAN 100 ML; CONTAINS 118 MG SODIUM CARBONATE PER GRAM OF CEFTAZIDIME ACTIVITY
TOTAL PRIMARY CONTAINER QUANTITY: 10

TAZIDIME

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505012314806

NSN

6505-01-231-4806

View More Info

TAZIDIME

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505012314806

NSN

6505-01-231-4806

MFG

ELI LILLY AND COMPANY DBA ELI LILLY

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME FOR INJECTION USP 1GM BOTTLE 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE
SPECIAL FEATURES: BOTTLE WITH A RATED CAPACITY OF NOT LESS THAN 100 ML; CONTAINS 118 MG SODIUM CARBONATE PER GRAM OF CEFTAZIDIME ACTIVITY
TOTAL PRIMARY CONTAINER QUANTITY: 10

TAZIDIME INJECTION

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505012314806

NSN

6505-01-231-4806

View More Info

TAZIDIME INJECTION

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505012314806

NSN

6505-01-231-4806

MFG

ELI LILLY AND COMPANY DBA ELI LILLY

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME FOR INJECTION USP 1GM BOTTLE 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE
SPECIAL FEATURES: BOTTLE WITH A RATED CAPACITY OF NOT LESS THAN 100 ML; CONTAINS 118 MG SODIUM CARBONATE PER GRAM OF CEFTAZIDIME ACTIVITY
TOTAL PRIMARY CONTAINER QUANTITY: 10

FORTAZ

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505012314808

NSN

6505-01-231-4808

View More Info

FORTAZ

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505012314808

NSN

6505-01-231-4808

MFG

GLAXO WELLCOME INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 6.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME FOR INJECTION 6GM MULTI-DOSE VIAL 6S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 6.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: EACH VIAL CONTAINS CEFTAZIDIME PENTAHYDRATE EQUIVALENT TO 6 GRAMS OF CEFTAZIDIME,AND 118 MILLIGRAMS SODIUM CARBONATE PER GRAM OF CEFTAZIDIME; PHARMACY BULK PACK
TOTAL PRIMARY CONTAINER QUANTITY: 6

NDC00002-7241-16

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505012314808

NSN

6505-01-231-4808

View More Info

NDC00002-7241-16

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505012314808

NSN

6505-01-231-4808

MFG

ELI LILLY AND COMPANY DBA ELI LILLY

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 6.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME FOR INJECTION 6GM MULTI-DOSE VIAL 6S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 6.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: EACH VIAL CONTAINS CEFTAZIDIME PENTAHYDRATE EQUIVALENT TO 6 GRAMS OF CEFTAZIDIME,AND 118 MILLIGRAMS SODIUM CARBONATE PER GRAM OF CEFTAZIDIME; PHARMACY BULK PACK
TOTAL PRIMARY CONTAINER QUANTITY: 6

NDC00173-0382-37

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505012314808

NSN

6505-01-231-4808

View More Info

NDC00173-0382-37

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505012314808

NSN

6505-01-231-4808

MFG

GLAXO WELLCOME INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 6.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME FOR INJECTION 6GM MULTI-DOSE VIAL 6S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 6.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: EACH VIAL CONTAINS CEFTAZIDIME PENTAHYDRATE EQUIVALENT TO 6 GRAMS OF CEFTAZIDIME,AND 118 MILLIGRAMS SODIUM CARBONATE PER GRAM OF CEFTAZIDIME; PHARMACY BULK PACK
TOTAL PRIMARY CONTAINER QUANTITY: 6

TAZIDIME POWDER

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505012314808

NSN

6505-01-231-4808

View More Info

TAZIDIME POWDER

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505012314808

NSN

6505-01-231-4808

MFG

ELI LILLY AND COMPANY DBA ELI LILLY

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 6.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME FOR INJECTION 6GM MULTI-DOSE VIAL 6S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 6.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: EACH VIAL CONTAINS CEFTAZIDIME PENTAHYDRATE EQUIVALENT TO 6 GRAMS OF CEFTAZIDIME,AND 118 MILLIGRAMS SODIUM CARBONATE PER GRAM OF CEFTAZIDIME; PHARMACY BULK PACK
TOTAL PRIMARY CONTAINER QUANTITY: 6

CYTOMEL

LIOTHYRONINE SODIUM TABLETS,USP

NSN, MFG P/N

6505012315697

NSN

6505-01-231-5697

View More Info

CYTOMEL

LIOTHYRONINE SODIUM TABLETS,USP

NSN, MFG P/N

6505012315697

NSN

6505-01-231-5697

MFG

JMI-CANTON PHARMACEUTICALS INC SUB OF JONES MEDICAL INDUSTRIES INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MICROGRAMS LIOTHYRONINE SODIUM ACTIVE INGREDIENT
FEATURES PROVIDED: ENTERIC COATED AND SCORED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LIOTHYRONINE SODIUM TABLETS USP 25MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE, GLASS
THERAPEUTIC EQUIVALENT: RATED AB

01801

HEPARIN LOCK FLUSH SOLUTION,USP

NSN, MFG P/N

6505012315698

NSN

6505-01-231-5698

View More Info

01801

HEPARIN LOCK FLUSH SOLUTION,USP

NSN, MFG P/N

6505012315698

NSN

6505-01-231-5698

MFG

SOLOPAK MEDICAL PRODUCTS INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 UNITS HEPARIN SODIUM PER MILLILITER
FEATURES PROVIDED: STERILE
III THERAPEUTIC EQUIVALENT: RATED AP
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
RAW MATERIAL SOURCE: PORCINE INTESTINAL MUCOSA
SPECIAL FEATURES: SINGLE DOSE VIAL; PRESERVATIVE FREE
TOTAL PRIMARY CONTAINER QUANTITY: 25

93001

HEPARIN LOCK FLUSH SOLUTION,USP

NSN, MFG P/N

6505012315698

NSN

6505-01-231-5698

View More Info

93001

HEPARIN LOCK FLUSH SOLUTION,USP

NSN, MFG P/N

6505012315698

NSN

6505-01-231-5698

MFG

ASTELLAS PHARMA US INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 UNITS HEPARIN SODIUM PER MILLILITER
FEATURES PROVIDED: STERILE
III THERAPEUTIC EQUIVALENT: RATED AP
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
RAW MATERIAL SOURCE: PORCINE INTESTINAL MUCOSA
SPECIAL FEATURES: SINGLE DOSE VIAL; PRESERVATIVE FREE
TOTAL PRIMARY CONTAINER QUANTITY: 25

NDC00469-3001-15

HEPARIN LOCK FLUSH SOLUTION,USP

NSN, MFG P/N

6505012315698

NSN

6505-01-231-5698

View More Info

NDC00469-3001-15

HEPARIN LOCK FLUSH SOLUTION,USP

NSN, MFG P/N

6505012315698

NSN

6505-01-231-5698

MFG

ASTELLAS PHARMA US INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 UNITS HEPARIN SODIUM PER MILLILITER
FEATURES PROVIDED: STERILE
III THERAPEUTIC EQUIVALENT: RATED AP
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
RAW MATERIAL SOURCE: PORCINE INTESTINAL MUCOSA
SPECIAL FEATURES: SINGLE DOSE VIAL; PRESERVATIVE FREE
TOTAL PRIMARY CONTAINER QUANTITY: 25